Published in Blood Weekly, May 2nd, 2002
"Expansion of stem cells from cord blood has been demonstrated to increase the numbers of CD34+ cells, CD34+ subsets, long-term culture-initiating cells, and severe combined immunodeficient mouse repopulating cells," explained Dr. G. Dravid and colleagues at the Cancer Research Institute in Mumbai. "However, reports suggest that the ex vivo expanded population behaves differently than freshly isolated cells and shows a delayed or diminished...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.